Subcutaneous implantation of pure crystalline estradiol pellets for conception control

Gynecologic and Obstetric Investigation

Volumn 59, Issue 3, 2005, Pages 119-125

  Oettinger, Moshe ^a,b   Barak, Shlomi ^b   Oettinger Barak, Orit ^b   Ophir, Ella ^a,b  

^a WESTERN GALILEE HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Conception control; Estradiol pellets

Indexed keywords

ESTRADIOL; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ADVISORY COMMITTEE; ARTICLE; BIRTH CONTROL; BREAST TENDERNESS; CONTRACEPTION; CONTROLLED STUDY; DRUG APPROVAL; DRUG EFFICACY; DRUG PELLET; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE FERTILITY; FIRST PASS EFFECT; FOLLOW UP; HEADACHE; HUMAN; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UTERUS BLEEDING; WITHDRAWAL BLEEDING; FERTILITY; HYPERPLASIA; MAJOR CLINICAL STUDY;

ADULT; BIOPSY; CONTRACEPTIVE AGENTS, FEMALE; CRYSTALLIZATION; DRUG IMPLANTS; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; TIME FACTORS;

EID: 20944443968     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082652     Document Type: Article

References (26)

1. Deanesly R, Parkes FRS: Factors influencing the effectiveness of administered hormones. Proc R Soc Lond 1937;124:279-298.
2. Corner GW: The Hormones in Human Reproduction. Princeton, Princeton University Press, 1942, p 192.
3. Greenblatt RB, Suran RR: Indications for hormonal pellets in the therapy of endocrine and gynecic disorders. Am J Obstet Gynecol 1949; 57:294-301.
4. Emperaire JC, Greenblatt RB: Contraception by implantation of estradiol pellets. Gynecol Prat 1969;20:327-335.
5. Greenblatt RB, Hair LQ: Testosterone propionate pellet absorption in the female. J Clin Endocrinol 1942;2:315-317.
6. Greenblatt RB, Asch RH, Mahesh VB, Bryner JR: Implantation of pure crystalline pellets of estradiol for conception control. Am J Obstet Gynecol 1977;127:520-524.
7. Diczfalusy E, Fraksson C, Lisboa BP, Martinsen B: Formation of oestrone glucosiduronate by the human intestinal tract. Acta Endocrinol 1962;40:537-551.
8. Steingold KA, Cefalu W, Pardridge W, Judd HL, Chaudhuri G: Enhanced hepatic extraction of estrogens used for replacement therapy. J Clin Endocrinol Metab 1986;62:761-766.
9. Beral V: Royal College of General Practitioners' Oral Contraception Study: Mortality among oral contractive users. Lancet 1977;ii: 727-731.
10. Royal College of General Practitioners' Oral Contraception Study: Further analysis of mortality in oral contractive users. Lancet 1981;i: 541-546.
11. Brook JG, Aviram M, Oettinger M, Sharf M: The effect of oestrogen implants on high density lipoproteins and its subfractions in women in their pre-mature menopause. Maturitas 1982;4:257-265.
12. Oettinger M, Yeshurun D, Lanir A, Kahana L, Degani S, Sharf M: Subcutaneous implantation of purely crystalline 17β-estradiol and its effect on blood lipids and lipoproteins. Maturitas 1984;6:158.
13. Sharf M, Oettinger M, Lanir A, Kahana L, Yeshurun D: Lipid and lipoprotein levels following pure estradiol implantation in postmenopausal women. Gynecol Obstet Invest 1985;19:207-212.
14. Ball MJ, Ashwell E, Gillmer MD: Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone. Contraception 1991;44:223-233.
15. Krauss RM: The tangled web of coronary risk factors. Am J Med 1991:90S:36-41.
16. Verheugen C, Pardridge WM, Judd HL, Chaudhuri G: Differential permeability of uterine and liver vascular beds to estrogens and estrogen conjugates. J Clin Endocrinol Metab 1984;59:1128-1132.
17. Geola FL, Frumar AM, Tataryn IV, Lu KH, Hershman JM, Eggena P, et al: Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1980;51:620-625.
18. Goebelsmann U, Mashchak CA, Mishell DR Jr: Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol. Am J Obstet Gynecol 1985;151:868-877.
19. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, et al: Biologic effects of transdermal estradiol. N Engl J Med 1986;314:1615-1620.
20. Corson SL: Contraception for women with health problems. Int J Fertil 1996;41S:545-552.
21. Nezhat C, Karpas AE, Greenblatt RB, Mahesh VB: Estradiol implants for conception control. Am J Obstet Gynecol 1980;138:1151-1156.
22. Diczfalusy E, Landgren BM: How normal is the normal cycle?; in Crosignani PG, Rubin BL (eds): Endocrinology of Human Infertility: New Aspects, No 2. London, Academic Press/ New York, Grune & Stratton, 1981, pp 1-25.
23. Hatcher RA, Trussell J, Stewart F, et al (eds): Contraceptive Technology, ed16. New York, Irvington Publishers, 1994.
24. Trussell J, Kost K: Contraceptive failure in the United States: A critical review of the literature. Stud Am Plann 1987;18:237.
25. Serfaty D: Medical aspects of oral contraceptive discontinuation. Adv Contracept 1992;8: 21.
26. Rosenberg MJ, Waugh MS, Long S: Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med 1995;40:355.